Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2014-05-28 Major Shareholding Noti…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding where 'Friends Life Group Limited' sold shares of 'CellaVision AB', resulting in their holding dropping below a threshold (implied by the 'Reason for major shareholding notification Sell' and the resulting percentage). The structure, including 'Before the transaction', 'After the transaction', 'Resulting distribution of total holdings', and 'Group total holdings', is characteristic of a notification regarding significant ownership changes. This aligns directly with the definition for Major Shareholding Notification (MRQ). The document length is short (2601 chars), but the content is the notification itself, not an announcement of a report.
2014-05-28 English
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 1% confidence The document explicitly details a change in shareholding ('Reason for major shareholding notification Buy') for the issuer CellaVision AB, held by Friends Life Group Limited. It specifies the number of shares (1,202,732) and the resulting percentage of voting rights (5.04%). This content directly aligns with the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds.
2014-05-23 English
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage for a specific instrument (Aktier SE0000683484) by a holder (Nordnet AB (publ)). It explicitly mentions 'Reason for major shareholding notification Sell' and provides 'Before the transaction' and 'After the transaction' figures, culminating in a 'Group total holdings' percentage of 3.75%. This structure perfectly matches the definition of a Major Shareholding Notification, which reports changes in significant ownership levels crossing thresholds.
2014-05-21 English
Kommuniké från årsstämma i CellaVision AB (publ) den 7 maj 2014
AGM Information Classification · 1% confidence The document is titled "Kommuniké från årsstämma i CellaVision AB (publ) den 7 maj 2014" which translates to 'Communiqué from the Annual General Meeting (AGM) in CellaVision AB (publ) on May 7, 2014'. It details the decisions made at the AGM, including dividend approval, granting discharge to the board and CEO, election/re-election of board members and auditor, approval of director fees, and decisions regarding an incentive program. These contents are characteristic of the official minutes or summary released following an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R).
2014-05-08 Swedish
Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 7, 2014
AGM Information Classification · 1% confidence The document explicitly states it is a 'Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 7, 2014' and details the resolutions passed, including dividend payment, board elections, and remuneration. This content directly relates to the proceedings and outcomes of the AGM. Therefore, the most appropriate classification is AGM Information (AGM-R). It is not a general regulatory filing (RNS) because it is highly specific to the AGM, nor is it a DEF 14A (Remuneration) or DVA (Voting Results) as it covers the entire scope of the meeting's decisions.
2014-05-08 English
CellaVision AB: Interim report January-March 2014
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report January–March 2014' and contains comprehensive financial statements, including a consolidated income statement, key ratios, and detailed management commentary on business performance, geographical markets, and R&D. It is clearly a quarterly financial report rather than an announcement or a summary, as it provides substantive financial data and analysis for the specified period. Q1 2014
2014-05-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.